# Deciphering the cardiac neuron landscape in heart failure patients

**Authors:** Shuping Zhuang, Xiuqi Yang, Nan Zhang, JiangQi Liu, Kaidong Liu, Huiming Han, Songmei Zhai, Mingyue Liu, Haihai Liang, Yunyan Gu, Yanjie Lu

PMC · DOI: 10.1371/journal.pcbi.1014082 · 2026-03-20

## TL;DR

This study maps heart neurons in heart failure patients, identifying a specific neuron type linked to disease progression and treatment response.

## Contribution

The study identifies N4-ALK neurons as a novel heart failure-associated subset and reveals their role in disease mechanisms and predictive modeling.

## Key findings

- N4-ALK neurons are significantly enriched in failing hearts and correlate with treatment response to left ventricular assist devices.
- The RXRG transcription factor and PTN-PTPRZ1 axis mediate regulatory interactions in N4-ALK neurons during heart failure.
- An N4-ALK-derived machine learning model improves heart failure patient identification at the population level.

## Abstract

Neurons exert a pivotal role in the preservation of cardiac physiological function. However, there is a lack of explanation about the mechanism of cardiac neurons in the pathogenesis of cardiac dysfunction. Here, we generated a cardiac neuron landscape including 11,026 neuronal cells based on the integration of published single-nucleus RNA sequencing data from 75 patients with heart failure and 45 healthy donors. We determined ten distinct neuronal cell subsets differing in abundances, compositions, and biological functions in the heart. In particular, N4-ALK neurons were significantly enriched in failing hearts relative to healthy controls, and their abundance was associated with the response to left ventricular assist device implantation. RXRG, a transcription factor highly expressed in neuronal cells, participated in the transcriptional regulatory network of N4-ALK neurons and showed a positive correlation with the expression of their marker genes. Notably, in heart failure, the PTN-PTPRZ1 axis mediated specific crosstalk between cardiac fibroblasts and N4-ALK neurons. Finally, we used N4-ALK-related features to develop an optimized prediction model for identifying individuals with heart failure. Overall, our integrative cardiac neuron atlas comprehensively characterizes the molecular and functional diversity of neuronal cells, providing a new perspective for further exploration of the regulatory function of neurons in heart failure.

The heart is a highly innervated organ and is innervated by both sympathetic and parasympathetic nerves, which is crucial for cardiac contraction and electrical signal transduction. Single-cell RNA sequencing offers a powerful resolution for dissecting cardiac neuromodulation by enabling the high-resolution characterization of specific neuronal populations. However, a generalized landscape of neurons in heart failure still remains insufficient. Here, our study systematically integrated current resources of neurons across heart failure researches, providing a perspective on the heterogeneity of cardiac neurons. Our findings first identified a subset of neurons, named N4-ALK, as a heart failure-associated neuronal subset, elucidated their disease-promoting role via the RXRG-PTN-PTPRZ1 axis, and offered new insights into heart failure pathophysiology. Beyond dissecting the underlying molecular mechanisms, we developed an N4-ALK-derived signature within a machine-learning framework to identify heart failure patients at the population level.

## Linked entities

- **Genes:** RXRG (retinoid X receptor gamma) [NCBI Gene 6258], PTN (pleiotrophin) [NCBI Gene 5764], PTPRZ1 (protein tyrosine phosphatase receptor type Z1) [NCBI Gene 5803]
- **Diseases:** heart failure (MONDO:0005252)

## Full-text entities

- **Genes:** PTPRZ1 (protein tyrosine phosphatase receptor type Z1) [NCBI Gene 5803] {aka HPTPZ, HPTPzeta, PTP-ZETA, PTP18, PTPRZ, PTPZ}, NRXN1 (neurexin 1) [NCBI Gene 9378] {aka Hs.22998, PTHSL2, SCZD17}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, LRRC4C (leucine rich repeat containing 4C) [NCBI Gene 57689] {aka NGL-1, NGL1}, PLP1 (proteolipid protein 1) [NCBI Gene 5354] {aka GPM6C, HLD1, MMPL, PLP, PLP/DM20, PMD}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, NRL (neural retina leucine zipper) [NCBI Gene 4901] {aka D14S46E, ESCS2, NRL-MAF, RP27}, ATF1 (activating transcription factor 1) [NCBI Gene 466] {aka EWS-ATF1, FUS/ATF-1, TREB36}, NRXN3 (neurexin 3) [NCBI Gene 9369] {aka C14orf60}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, CCL16 (C-C motif chemokine ligand 16) [NCBI Gene 6360] {aka CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC}, FGF12 (fibroblast growth factor 12) [NCBI Gene 2257] {aka DEE47, EIEE47, FGF12B, FHF1}, XKR4 (XK related 4) [NCBI Gene 114786] {aka XRG4, hXKR4}, DGKB (diacylglycerol kinase beta) [NCBI Gene 1607] {aka DAGK2, DGK, DGK-BETA}, PTN (pleiotrophin) [NCBI Gene 5764] {aka HARP, HB-GAM, HBBM, HBGF-8, HBGF8, HBNF}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, DR1 (down-regulator of transcription 1) [NCBI Gene 1810] {aka NC2, NC2-BETA, NC2B, NCB2}, RXRG (retinoid X receptor gamma) [NCBI Gene 6258] {aka NR2B3, RXR-gamma, RXRC, RXRgamma}, HIF3A (hypoxia inducible factor 3 subunit alpha) [NCBI Gene 64344] {aka HIF-3A, HIF3-alpha-1, IPAS, MOP7, PASD7, bHLHe17}, OGFRL1 (opioid growth factor receptor like 1) [NCBI Gene 79627] {aka dJ331H24.1}, ACSM3 (acyl-CoA synthetase medium chain family member 3) [NCBI Gene 6296] {aka SA, SAH}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, RFX1 (regulatory factor X1) [NCBI Gene 5989] {aka EFC, RFX}
- **Diseases:** coronary atherosclerosis (MESH:D003324), end-stage heart disease (MESH:D007676), ICM (MESH:D009202), DCM (MESH:D002311), weakness (MESH:D018908), cardiac dysfunction (MESH:D006331), heart injury (MESH:D006335), cardiomyocyte hypertrophy (MESH:D006984), Heart failure (MESH:D006333), oral submucous fibrosis (MESH:D009914), HCM (MESH:D002312), malignancy (MESH:D009369), cardiac fibrosis (MESH:D005355), glioblastoma (MESH:D005909), MI (MESH:D009203)
- **Chemicals:** N5 (MESH:C031785)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** SCP1303 — Homo sapiens (Human), Transformed cell line (CVCL_9F08), N4 — Mus musculus (Mouse), Transformed cell line (CVCL_D440), N4-ALK — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_SC35), PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13004344/full.md

---
Source: https://tomesphere.com/paper/PMC13004344